Patent · US Active

Vaccine for falciparum malaria

US11554165B2 · kind B2 · utility

0Cited by
16References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 17, 2021
Grant dateJan 17, 2023
Priority date—
Expiry dateFeb 17, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for preventing or reducing the severity of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.